Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/31448
Title: Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
Authors: 
Keywords: 
Mesh: 
Issue Date: 2017
Citation: BMC Cardiovasc Disord.2017 06;(17)1:160
Abstract: Atherogenic dyslipidemia is associated with poor cardiovascular outcomes, yet markers of this condition are often ignored in clinical practice. Here, we address a clear evidence gap by assessing the prevalence and treatment of two markers of atherogenic dyslipidemia: elevated triglyceride levels and low levels of high-density lipoprotein cholesterol.
PMID: 28623902
URI: https://hdl.handle.net/20.500.12530/31448
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC5473961.pdf983.8 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.